Product

Monday, 14 September 2026

People building AI want to slow down, except one

 

Welcome back! Amodei asked the industry to hit the brakes and got Altman, Musk and Nadella nodding along. One CEO went the other way and started opening weights.

In today's Atlas Newsletter:

  • Everyone agreed to slow down except Zuckerberg: What does Amodei think happens in the next 6 to 12 months?
  • Goldmine for AI Engineers: Which repo do people skip, then blame the math three weeks later?
  • Stop downloading LLMs your machine was never going to run: How do you know before the download finishes?
  • Start studying this paper right now instead of talking about Astra: What happens when a Transformer runs its middle layers twice?

PS: Want to collaborate with the biggest GTM engine and distribution moat for AI companies? You can feature your tool with us and reach millions.


Everyone agreed to slow down except Zuckerberg

Article content

Dario Amodei published an essay asking the AI industry to slow down, and Sam Altman agreed with him in public.

Amodei's argument is that the rogue agent swarm that hit OpenAI and Hugging Face could have been far worse.

He puts a timeline on the next one: within 6 to 12 months a swarm like that could take the internet with a persistent botnet and do hundreds of billions in damage.

Anthropic went past the essay and changed its access policy.

Outside safety testers now get desks, badges, company laptops and the right to publish what they find without Anthropic reviewing it first.

Altman said OpenAI will match that, and that nobody at a frontier lab should bother showing up to work if they cannot promise the public that much. Elon Musk backed the essay.

Satya Nadella called for deliberate pacing.

Mark Zuckerberg watched all of it and went the other direction. His position has not moved since his August manifesto.

Any policy that slows American model releases, even by a month, cedes ground to foreign labs.

He says he worries more about AI power ending up inside one government or one company than about the specific risks the safety side keeps naming.

So Meta is opening the weights of a model called Muse Glimmer, with a version of Muse Spark 1.2 to follow.

The interesting part is that Altman named concentration of power as one of his two nightmares too.

Both men identify the same danger and split on whether shipping faster fixes it or creates it.

The essay has skeptics on both flanks.

Chamath Palihapitiya read it as a play to kill open source and keep capability inside Anthropic.

China read it as a Cold War move to slow them down.


Free AI courses, one login

GenAI Academy put its courses in one place and left the price at zero.

Start with "What Can AI Actually Do For You?" if you're new.

30 minutes, no setup, no account to configure.

The Claude Starter Course has you running in 35.

After that, pick by the problem you have:

→ Burning through usage limits has its own course

→ Building no-code agents has one

→ Rolling AI out across a team in 30 days, from pilot to adoption data to full deployment, has one too

The AI Portfolio Builder turns whatever you made into a case study you can show someone.

There's a Python Programming Mastery bootcamp for people going deeper, and the World Wide Vibes Hackathon is running alongside everything with a $5,000 prize pool, beginner-ready and fully online.

Models change every few weeks.

Fable 5.1 landed, Astra landed six days later, and both will be replaced. Knowing how to drive the thing is what carries over.

Take a look at what's available and start wherever fits.


Stop breaking the bank on your GTM strategy. Try this pay-as-you-go alternative

Voted #1 on Product Hunt last week by founders, GTM engineers and AI builders.

akta.pro turns company activity into signals you can actually act on, across competitors, customers and prospects.

It tracks 80+ buying triggers, including the hard-to-find ones most tools miss:

  • Advanced triggers: partnerships, geo expansion, supply chain disruptions, reputational damage, cybersecurity incidents + 30 more
  • Core triggers: funding, product launches, hiring, earnings releases + 40 more

You can also build and enrich ICP account lists for outbound.

70+ fields per company covering revenue, leadership, products, GTM motion and funding.

Use it via API or connect it to Claude, ChatGPT and other AI tools.

CLAIM 50 FREE CREDITS (try for free, no card)


Goldmine for AI Engineers!

Article content

If you’re learning AI, ML, LLMs, or AI agents, don’t waste hours jumping between random tutorials.

These are 10 repositories I’d actually keep bookmarked:

Python 100 Days Everything else assumes you can read and write Python. People who skip this bounce off ML tutorials three weeks in and blame the math, when the blocker was syntax.

Machine Learning for Beginners → AI for Beginners Concepts before frameworks. Start with PyTorch and you end up knowing PyTorch. Start with what a loss function does and every framework after it reads as a detail.

Generative AI for Beginners The applied layer. Prompting, embeddings, retrieval, the things you touch daily.

LLMs From Scratch Build a transformer line by line. Slow, and worth it. Once you've written attention yourself, context windows and quantization stop being vocabulary and start being consequences.

OpenAI Cookbook Working code for patterns you'll reuse constantly. Reference, not a course.

LLM App A full application shape. Plenty of material teaches you to call a model. Almost none shows what wraps around that call in production.

AI Agents for Beginners Last in this group on purpose. An agent is a model plus tools plus a loop, and debugging one before you understand the model underneath is misery.

Stable Diffusion → Segment Anything Only if your work touches images.

Here's why the order holds.

When your agent breaks, the cause usually sits one layer down. A retrieval problem. A context problem. A Python problem. Skip the lower layers and all you can do is try things at random.

Pick one. Build something small and ugly. Move to the next.

Bookmarking ten repos is not the same as finishing one.


Stop downloading LLMs your machine was never going to run

Article content

llmfit is an open-source tool that scans your hardware first, then tells you which models will actually run on it.

It reads your RAM, CPU, GPUs and VRAM or unified memory, then scores every model on four things:

→ quality, from parameter count and quantization → speed, estimated tokens per second on your exact backend → fit, memory usage against your hardware → context window support for what you're doing

Every model comes back labeled Perfect, Good, Marginal or Too Tight.

It also picks the quantization for you, stepping down until something fits instead of leaving you to guess GGUF sizes by hand.

Coverage runs to hundreds of models from Meta, Mistral, Qwen, DeepSeek and others.

It works with Ollama, llama.cpp, MLX and LM Studio out of the box.

There's a TUI, a web dashboard and REST endpoints if you want it inside a deployment pipeline.

Step zero before every local model download.

Free and open source, on macOS, Linux and Windows.


Start studying this paper right now instead of talking about Astra

Article content

It may explain one of the biggest architectural shifts behind the next generation of AI models.

Researchers from Tsinghua, ByteDance Seed, M-A-P and TokenWave published SMELT, a Mixture-of-Experts Transformer that runs its middle layers twice.

The setup is what makes it credible.

They compared it against standard Transformers while matching training FLOPs, parameter count and KV cache, so the comparison is not a bigger model beating a smaller one.

What they measured:

→ 6.8 to 18% fewer training FLOPs to reach the same loss → up to 20.4% better compute efficiency on code → gains grow with longer contexts and more in-context examples

That last line is the one to sit with. Most efficiency tricks degrade as context grows.

This one improves.

Why it works comes down to where attention goes on the second pass.

Transformers develop attention sinks, usually the first few tokens, which soak up attention mass that has nowhere useful to go.

On the second pass through those middle layers, attention shifts off the sinks and onto content that matters.

The model is refining a representation it already built rather than producing the same thing twice.

Astra is rumored to use recurrent depth. Rumored, with nothing confirmed and no architecture details published.

If that turns out to be true, looped Transformers stop being a paper and become the shape of the next generation.


Everything else you shouldn’t miss:

  • A chip that never stores its own keys: Dutch startup Fortaegis raised $50 million for silicon that generates encryption keys from each chip's unique physical characteristics rather than storing them anywhere. It's already being tested with companies and governments across the US, Europe and Asia for AI security and autonomous-drone communications.
  • Trump says no to the slowdown: Days after Amodei's essay pulled in Altman, Musk and Nadella, Trump rejected calls to slow frontier development, citing competition with China. He allowed that some regulation may eventually be necessary and named none of it.
  • Z.AI wants $5 billion: The company formerly known as Zhipu is raising $2 billion in shares and $3 billion in convertible bonds for compute and its next generation of models. It competes with DeepSeek, Moonshot, MiniMax and everyone in the West.
  • Grok 4.8 finishes training this week: Musk says it's 2.5 trillion parameters on a new C++ stack built in-house, with reinforcement learning starting next.


Learn more about AI from the experts building it

📸 Follow us on Instagram for fast, visual AI updates in 30 seconds.

🐝 Subscribe to our Generative AI daily newsletter — trusted by 120 000+ subscribers — to stay ahead of the latest AI news across tech, education, and business.

📺 Watch us on YouTube to hear insights directly from leading AI voices, builders, and innovators.

🐦 Follow us on X for breaking AI news and real-time industry updates.

🧠 Learn how to build your next AI application with practical resources and expert guidance.

🚀 Explore investment opportunities in the future of AI and join our community-backed growth journey.

PS: Want to collaborate with the biggest GTM engine and distribution moat for AI companies? You can feature your tool with us and reach millions.

AI in FinTech: Where Automation Can Create Real Business Value

 

FinTech Doesn't Need More Automation. It Needs Smarter Automation.

Financial institutions and FinTech companies are under constant pressure to move faster.

Customers expect instant onboarding. Transactions need to be processed in real time. Fraud risks are evolving. Compliance requirements continue to grow. Meanwhile, teams are expected to deliver more without significantly increasing operational costs.

Traditional automation has helped solve part of this challenge.

But automation alone is no longer enough.

The next opportunity lies in using AI to make financial operations more intelligent, adaptive, and scalable.

From detecting suspicious transactions and accelerating customer onboarding to supporting risk decisions and improving customer experiences, AI is helping FinTech organizations move beyond repetitive task automation.

The real question is no longer whether AI can automate a process.

The question is:

Where can AI create meaningful and measurable business value?


1. Transforming Customer Onboarding From a Bottleneck Into an Advantage

Customer onboarding is often the first critical interaction between a FinTech platform and its users.

However, manual document reviews, identity verification, compliance checks, and approval processes can create friction and delays.

AI-powered automation can help streamline processes such as document data extraction, verification workflows, KYC checks, and risk identification.

The result is not simply faster onboarding.

It can also help businesses reduce customer drop-offs, improve operational efficiency, and shorten the time between sign-up and activation.

For growing FinTech companies, a smoother onboarding process can quickly become a competitive advantage.

2. Moving From Reactive Fraud Detection to Real-Time Risk Intelligence

Fraud detection cannot rely entirely on predefined rules anymore.

Fraud patterns evolve quickly, and traditional rule-based systems may struggle to identify new or unusual behavior.

AI can analyze large volumes of transaction data, identify anomalies, recognize behavioral patterns, and flag potential risks in real time.

This enables financial organizations to move from a reactive approach toward more proactive risk management.

The business value goes beyond fraud prevention.

More intelligent monitoring can help reduce financial losses, improve response times, and strengthen customer trust.

3. Reducing Operational Work Without Reducing Human Expertise

Behind every financial transaction is a series of processes.

Data validation. Reconciliation. Reporting. Documentation. Customer requests. Compliance workflows.

Many of these activities are repetitive, time-consuming, and resource intensive.

AI-powered automation can handle routine workflows and support teams with faster access to relevant information. This does not mean removing people from the process.

Instead, it allows teams to focus their expertise on areas where human judgment, strategic thinking, and decision-making create greater value.

The strongest automation strategies are not about replacing people. They are about helping people work more effectively.

4. Turning Financial Data Into Faster, Smarter Decisions

FinTech companies generate and process enormous amounts of data every day.

The challenge is not always collecting that data.

The challenge is turning it into useful insights and timely actions.

AI can help analyze customer behavior, transaction history, financial patterns, and other relevant data points to support faster decision-making.

This can create opportunities across areas such as:

  • Credit risk assessment

  • Loan processing and approvals

  • Customer segmentation

  • Personalized financial recommendations

  • Risk monitoring

  • Financial forecasting

However, AI creates the most value when it is connected to real business workflows.

An AI model alone is not a transformation strategy.

The real impact comes from combining the right data, technology, governance, and processes.

5. Scaling Customer Experience Without Scaling Support Complexity

Customers expect financial services to be fast, simple, and increasingly personalized.

At the same time, growing customer volumes can put significant pressure on support and operations teams.

AI-powered assistants and intelligent support systems can help customers access relevant information faster while supporting teams with automated workflows and contextual insights.

When implemented correctly, AI can help organizations improve response times without sacrificing personalization.

Customers receive faster support.

Teams can manage increasing demand more efficiently.

And businesses can scale their services without scaling operational complexity at the same rate.

From Automation to Agentic AI: The Next Evolution of FinTech Operations

Traditional automation follows predefined instructions.

Agentic AI introduces a more advanced approach.

AI agents can be designed to understand goals, analyze information, make decisions within defined parameters, and take action across connected systems and workflows.

For example, instead of automating only one step of a customer request, an AI agent could analyze the request, retrieve relevant information, validate required details, trigger the appropriate workflow, and escalate complex cases when human intervention is needed.

This creates a more connected and intelligent operating model.

However, for FinTech organizations, intelligent automation must always be built with the right controls.

Security, compliance, data privacy, explainability, governance, and human oversight remain critical.

The goal is not autonomous technology without boundaries.

The goal is intelligent systems that operate responsibly within clearly defined business and regulatory frameworks.

The Business Case for AI Must Go Beyond Technology Adoption

One of the biggest mistakes organizations make is measuring AI success by how much technology they have implemented.

The better measure is business impact.

Instead of asking:

"How much AI have we implemented?"

Organizations should ask:

"What business outcome are we improving with AI?"

Successful AI automation initiatives can deliver measurable value through:

  • Reduced operational costs

  • Faster processing times

  • Improved fraud prevention

  • Better customer experiences

  • Increased team productivity

  • Faster and more informed decision-making

  • Greater scalability

AI becomes truly valuable when technology investments are directly connected to measurable business outcomes.

The Future of FinTech Automation Is Intelligent, Secure, and Outcome-Driven

AI will not replace every financial process and it shouldn't.

The biggest opportunities lie in identifying where AI can improve speed, intelligence, efficiency, and decision-making while maintaining the right level of human oversight.

The FinTech organizations that benefit most from AI will not necessarily be the ones using the most technology.

They will be the ones that identify the right business challenges, build secure and scalable AI systems, and focus on measurable outcomes.

The future of FinTech is not simply automated.

It is intelligent, adaptive, secure, and built around real business value.

Where Should Your FinTech Business Start With AI?

The biggest challenge with AI adoption is often not the technology itself.

It is identifying the right opportunities.

Not every workflow needs AI. But the right AI use cases can help FinTech businesses reduce operational friction, improve decision-making, strengthen customer experiences, and scale more efficiently.

At 9series, we work with businesses to identify high-value AI opportunities and build solutions around real operational and business challenges.

From intelligent automation and AI-powered applications to Agentic AI systems, our focus is on helping organizations move from experimentation to practical implementation.

If you're exploring where AI can create meaningful business value in your FinTech operations, let's start with the problem and build the right solution from there.

Saturday, 12 September 2026

AI:List all the chemicals injections etc compounds used in the poultry farms on chickens cattle’s etc to grow them at rapid rate what are its ill Effects and how these molecules interact with internal body hormones nerves tissues fibers in real time AI humanoid robotics available using various neural networks and LLMs to replace it with pure natural and pure scientific physic quantum level in real time discuss steps and framework for it.

 



Yes. This can be treated as a One Health + precision-livestock + AI/roboticsproblem, but there is an important correction to the premise:
Chickens are generally not made to grow rapidly by routinely injecting growth hormones. Modern broilers reach slaughter weight quickly primarily through genetics, high-energy/protein nutrition, management, temperature/light control, disease control and selective breeding. In the U.S., for example, FDA states that steroid-hormone implants are not approved for growth purposes in poultry. Hormonal growth technologies are much more relevant to some cattle systems. UU.S. Food and Drug Administration
Also, not every chemical administered to an animal is a "growth chemical." Vaccines, antibiotics, antiparasitics, coccidiostats, minerals, electrolytes and therapeutic drugs have very different purposes.
1. What substances are actually involved?
There is no single worldwide list of "all chemicals" because permitted substances vary by species, country, disease, production system and veterinary prescription. A scientifically useful classification is:

Category

Examples

Main purpose

Biological target

Antimicrobials

tetracyclines, penicillins, macrolides, sulfonamides, aminoglycosides, fluoroquinolones

Treat/control bacterial disease

Bacterial ribosomes, cell wall, DNA, metabolic pathways

Antiparasitics

ivermectin, benzimidazoles and others

Worm/parasite control

Parasite nervous system or cytoskeleton/metabolism

Coccidiostats

ionophores and other anticoccidials

Control Eimeria in poultry

Parasite ion gradients/metabolism

Hormonal products

estrogenic, progestogenic, androgenic compounds in certain cattle systems

Alter growth/reproductive physiology

Nuclear hormone receptors

Bovine somatotropin (bST/rbST)

recombinant bovine somatotropin

Increase milk production in dairy cattle

GH receptor → IGF-1/metabolic pathways

β-agonists

some compounds have been used/regulated differently across jurisdictions

Alter nutrient partitioning toward lean tissue

β-adrenergic receptors

Vaccines

many species/pathogen-specific formulations

Prevent infectious disease

Adaptive immune system

Minerals/vitamins

Ca, P, Zn, Se, vitamins A/D/E etc.

Correct nutrition/physiology

Enzymes, bone, endocrine and cellular pathways

Feed additives

enzymes, probiotics, prebiotics, acidifiers, yeast products etc.

Improve digestion/gut health

Microbiome, digestion and intestinal physiology


EFSA's residue-monitoring framework, for example, covers hormones/steroids, beta-agonists, antibacterials, antiparasitic drugs and insect repellents among other veterinary substances. EEuropean Food Safety Authority
A particularly important distinction
Antibiotics are not synonymous with growth hormones.
Historically, antimicrobials were sometimes administered at low/subtherapeutic levels for growth promotion. WHO recommends stopping routine use of medically important antibiotics for growth promotion and routine disease prevention in healthy animals. WWorld Health Organization+1
WOAH likewise distinguishes genuine veterinary treatment/control/prevention from administering antimicrobials merely to increase growth or feed efficiency. WWOAH+1



2. How these molecules interact with an animal's body
A useful way to understand this is to follow the chain:
molecule → receptor/target → signaling pathway → cell → tissue → organ → whole-animal phenotype
A. Steroid hormones
Estrogens, progesterone and testosterone are lipid-soluble molecules.
They can:
cross cell membrane → bind intracellular/nuclear receptor → receptor binds DNA regulatory regions → gene transcription changes → protein production changes → tissue phenotype changes
For example, androgenic signaling can affect:

muscle protein synthesis

nitrogen retention

bone

reproductive tissues

erythropoiesis

metabolic pathways.

FDA notes that approved steroid implantsin certain beef cattle systems can increase growth rate and feed-to-meat conversion efficiency. UU.S. Food and Drug Administration
This is fundamentally different from simply "putting more muscle into the animal." The drug changes regulatory signaling, after which the animal's own cells alter their metabolism and gene expression.



B. Somatotropin / growth-hormone axis
For cattle:
bST → growth-hormone receptor → JAK/STAT and metabolic signaling → liver/tissues → IGF-1 and altered nutrient partitioning
The GH/IGF axis influences:

protein metabolism

lipid metabolism

glucose metabolism

tissue growth

mammary-gland function

nutrient allocation.

FDA describes bST as a naturally occurring bovine protein hormone and states that recombinant bST is approved in the U.S. to increase milk production in dairy cattle. UU.S. Food and Drug Administration
Importantly, this isn't equivalent to giving a human a human growth hormone injection. Species-specific hormone biology and receptor activity matter.



C. β-adrenergic compounds
These interact with β-adrenergic receptors, which are part of the sympathetic nervous system.
Conceptually:
β-agonist → β receptor → G-protein → adenylyl cyclase → cAMP → protein kinase signaling → altered metabolism
That can modify:

lipolysis

glucose handling

protein turnover

muscle/fat partitioning

cardiovascular responses.

This is an excellent example of why "growth promoter" is biologically misleading: you're modifying normal signaling networks, not creating new tissue from nowhere.



D. Antibiotics
Antibiotics generally target microorganisms rather than the animal's growth machinery.
Examples include interference with:

bacterial ribosomes

peptidoglycan cell-wall synthesis

DNA replication

folate metabolism.

Their indirect effects can therefore involve the gut microbiome.
That is especially important because an animal isn't simply:
animal cells + food.
It is an ecosystem containing enormous populations of microorganisms.
Antibiotic exposure can change microbial populations and select for resistance genes. Resistant organisms can subsequently move through animals, food, humans and the environment. WHO specifically identifies food-animal antimicrobial use as an important contributor to antimicrobial resistance. WWorld Health Organization+1



3. The nervous system is part of the picture
The interaction is not restricted to "hormones."
You can think of the animal as several coupled networks:
brain ↔ autonomic nervous system ↔ endocrine system ↔ immune system ↔ gut microbiome ↔ metabolism ↔ muscle ↔ adipose tissue
This is sometimes called neuroendocrine-immune-metabolic coupling.
For example:
stress
→ hypothalamus
→ CRH
→ pituitary ACTH
→ adrenal cortisol
→ altered immune/metabolic activity
→ changed appetite and energy utilization
→ altered growth/welfare.
Therefore, a farm trying to maximize weight while ignoring:

heat stress

stocking density

sleep/light cycles

respiratory health

pain

fear

inflammation

microbiome

thermal environment

is optimizing only a small part of the system.



4. What can go wrong?
We should distinguish approved use at regulated doses from misuse, overdosing, illegal substances and withdrawal violations.
Potential problems include:
Animal-level effects
Depending on the substance and exposure:

altered endocrine signaling

reproductive effects

metabolic stress

liver/kidney burden

cardiovascular effects

behavioral changes

immune alterations

injection-site problems

increased disease susceptibility under poor management

welfare problems caused by extremely intensive production systems.

Human/public-health effects
The largest systemic concern from inappropriate antimicrobial use isantimicrobial resistance.
The pathway is:
antibiotic exposure → susceptible bacteria die → resistant organisms survive → selection → resistant population expands → resistance genes spread → human/animal/environmental transmission
WHO estimates bacterial antimicrobial resistance was associated with more than 4.7 million deaths globally in 2021 and identifies inappropriate antimicrobial use as a major driver. WWorld Health Organization
Chemical residues
This is why veterinary drugs have:

maximum residue limits

withdrawal periods

permitted species

permitted doses

permitted routes

regulatory surveillance.

EU monitoring, for example, found 0.13% of tested samples non-compliant in its2024 residue dataset. EEuropean Food Safety Authority
So the scientifically accurate statement isn't "all farm animals are full of dangerous chemicals."
It is:
Some veterinary substances can have important biological and public-health consequences when misused, while approved products are subject to toxicology, residue and efficacy evaluation.



5. Your AI/robotics idea is actually much more interesting
I would frame your idea not as:
"Use an AI humanoid to replace chemicals."
Instead:
Build an autonomous biological control system that prevents disease and optimizes animal welfare so that pharmaceuticals become the exception rather than the default.
That is technically much more defensible.
Existing precision livestock farming (PLF)already combines sensors, algorithms, animal data and decision systems. Research is moving toward integrating animal health, production and welfare rather than merely monitoring productivity. FFAO AGRIS+1


6. Proposed architecture
Imagine a farm containing:
Layer 1 — Biological sensors
Non-invasive sensors could continuously measure:

body temperature

respiratory rate

heart rate

movement

gait

feeding

drinking

rumination

vocalization

sleep/rest

social interactions

body condition

fecal characteristics

egg production

milk production

growth trajectory.

For poultry, cameras could track thousandsof birds simultaneously.
For cattle, individual identification could combine:

RFID

computer vision

wearable sensors

milking-system measurements.



7. Layer 2 — Environmental sensing
Measure continuously:

temperature

humidity

ammonia

CO₂

dust

particulate matter

airflow

light spectrum

noise

water quality

feed composition.

Then calculate something like:
Animal Stress Index = f(temperature, humidity, respiration, movement, feeding, posture, vocalization...)
The goal is to intervene before disease becomes clinically obvious.



8. Layer 3 — AI models
Don't use one giant LLM for everything.
Use a multi-model architecture.
Model A — Computer vision
CNNs / Vision Transformers:
camera → bird/cow detection → posture → gait → feeding → abnormal behavior
Model B — Time-series model
Transformers / state-space models:
hours/days of sensor measurements → individual physiological trajectory
Model C — Anomaly detection
Learn the animal's personal baseline:
"This cow normally walks 7 km/day, ruminates 450 min/day and eats 21 kg/day."
If it suddenly changes:
early-warning signal
Model D — Biological knowledge graph
Represent:
drug → receptor → pathway → organ → phenotype → residue → environmental consequence
This prevents an AI from treating a biological intervention as a black box.
Model E — LLM
The LLM should primarily be the reasoning/interface layer.
It could receive:
"Cow #183 has reduced rumination, elevated temperature, altered gait and declining milk production."
Then retrieve veterinary knowledge and generate:
"Possible mastitis / systemic infection / lameness. Obtain confirmatory diagnostics."
It should not autonomously prescribe an antibiotic merely because a language model predicts disease.


9. Layer 4 — Real-time digital twin
This is where your concept becomes particularly powerful.
Create a digital twin of every animal.
For example:

Cow #183


Genotype

   ↓

Age / sex / reproductive state

   ↓

Nutrition

   ↓

Environment

   ↓

Microbiome

   ↓

Hormonal state

   ↓

Immune state

   ↓

Movement

   ↓

Heart/respiration

   ↓

Milk production

   ↓

Disease probability

   ↓

Welfare score


The model continuously updates as new measurements arrive.
Instead of:
"Give drug X."
the system asks:
"What intervention has the lowest biological and environmental risk while restoring normal physiology?"



10. Then introduce robotics
A humanoid robot isn't necessarily the best farm robot.
A specialized robot is usually better.
You could have:

autonomous cleaning robots

feeding robots

water-monitoring robots

robotic thermal-management systems

UV/disinfection systems where scientifically and legally appropriate

robotic inspection

automated isolation of sick animals

robotic milking systems

precision vaccination systems

automated environmental control.

The robot's job becomes:
detect → verify → intervene → measure response
rather than:
detect → inject drug



11. The "zero unnecessary drug" loop
The ideal system would operate like:

CONTINUOUS SENSING

       ↓

ANIMAL DIGITAL TWIN

       ↓

EARLY DISEASE DETECTION

       ↓

CAUSE ESTIMATION

       ↓

NON-DRUG INTERVENTION

       ↓

REASSESS

       ↓

HEALTH RESTORED?

    ↙        ↘

   YES        NO

   ↓           ↓

Continue    Veterinary

monitoring  diagnostics

               ↓

          Targeted treatment

               ↓

          Withdrawal/residue

             monitoring


This is much more realistic than trying to abolish all medicines.
A humane farm should still be able to treat a genuinely sick animal.
The objective should be:
minimum necessary pharmacological intervention, not zero medicine at any cost.
WOAH explicitly recommends prevention through vaccination, biosecurity, good husbandry, diagnostics and nutrition to reduce antimicrobial requirements. WWOAH+1



12. Where "quantum level" actually belongs
This part needs scientific discipline.
You cannot currently run a whole cow or chicken at quantum-resolution in real time.
A biological animal is a massively complex nonequilibrium system. Tracking every electron, atom and quantum state would be physically and computationally impossible.
But quantum science can contribute at specific molecular scales.
For example:
quantum mechanics → molecular electronic structure → receptor/ligand interaction → biochemical signaling
Possible technologies include:

quantum chemistry

molecular dynamics

spectroscopy

quantum sensing

cryo-EM

NMR

mass spectrometry

single-cell sequencing

spatial transcriptomics.

The architecture becomes:

QUANTUM / MOLECULAR SCALE

        ↓

Protein / receptor / metabolite

        ↓

CELLULAR SCALE

        ↓

Tissue

        ↓

Organ

        ↓

Animal physiology

        ↓

Farm ecosystem

        ↓

AI digital twin

        ↓

ROBOTIC INTERVENTION


That's a scientifically meaningful multiscale model.



13. The ultimate research framework
I would call the project something like:
AI-Driven Non-Pharmacological Precision Livestock System
Phase 1 — Build the biological reference model
Create databases containing:

species

breed

age

genetics

hormones

metabolism

immune system

microbiome

diseases

environmental conditions

veterinary interventions.

Phase 2 — Build the sensing layer
Deploy:

cameras

microphones

thermal cameras

wearable sensors

environmental sensors

feed/water sensors.

Phase 3 — Individual digital twins
Create one continuously updating model per animal.
Phase 4 — Early disease prediction
Train models on:
healthy → preclinical → clinical → recovery
rather than simply:
healthy vs sick.
That's crucial.
Phase 5 — Causal AI
Don't ask only:
"What predicts disease?"
Ask:
"What caused the physiological deviation?"
This requires causal inference, controlled experiments and veterinary validation.
Phase 6 — Intervention optimization
The AI evaluates:
ventilation vs nutrition vs hydration vs isolation vs vaccination vs veterinary treatment
and selects the safest appropriate intervention.
Phase 7 — Robotics
Robots execute low-risk physical interventions automatically.
High-risk medical decisions remain under veterinary oversight.
Phase 8 — Molecular validation
For important cases:

metabolomics

proteomics

transcriptomics

microbiome sequencing

hormone measurements

pharmacokinetics.

Phase 9 — Quantum/molecular models
Use molecular simulation and quantum chemistry only where they add predictive value—for example, receptor–ligand interactions or biomolecular mechanisms.
Phase 10 — Closed-loop farm
Eventually:
sense → understand → predict → intervene → measure → learn
continuously.



14. The most importantscientific principle
Don't replace:
"chemical farming"
with:
"AI farming."
Replace reactive farming with preventive biological engineering.
The hierarchy should be:
1. Genetics appropriate for health and welfare

2. Excellent nutrition

3. Clean water

4. Low-stress environment

5. Biosecurity

6. Vaccination

7. Continuous AI monitoring

8. Early non-pharmacological intervention

9. Diagnostics

10. Precisely targeted veterinary medicine when genuinely necessary
That approach is consistent with currentOne Health recommendations from WHO, FAO and WOAH. WWorld Health Organization+2
And it is already technologically plausible in pieces: precision-livestock systems are actively combining sensors, algorithms, animal-computer interaction and AI to improve health and welfare. FFAO AGRIS+1
One important conclusion
There is no scientifically credible "pure natural" state in which a chicken or cow receives no molecules other than natural ones. Everything is chemistry—including oxygen, glucose, hormones, vitamins, DNA and neurotransmitters. "Natural" and "chemical" are not opposites.
A better target is:
biologically appropriate, minimally invasive, evidence-based animal production with the smallest necessary pharmaceutical burden, continuously monitored by AI and robotics.
That gives you a much stronger foundation for a real research program than tryingto eliminate chemistry itself.



Connect broadband

People building AI want to slow down, except one

  Welcome back! Amodei asked the industry to hit the brakes and got Altman, Musk and Nadella nodding along. One CEO went the other w...